David Andrews - Concepedia

Author

David Andrews

Also Known As

Andrews, D.M., Andrews, David M., D Andrews, D M Andrews, D. ANDREWS, D. Andrews, D. M. ANDREWS, D. M. Andrews, D.M. ANDREWS, D.M. Andrews

115

Publications

2.8K

Citations

H-Index

107

Concepts

All Affiliations

AstraZeneca (United Kingdom)Harvard University Massachusetts General Hospital GlaxoSmithKline (United Kingdom)Goethe University Frankfurt

About

David Andrews is an author at AstraZeneca (United Kingdom) specializing in medicine, natural sciences, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	27	1.2K
2	Natural Sciences	16	23	1K
3	Engineering	4	4	138
4	Health Sciences	3	3	238
5	Law	1	1	44

David Andrews

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
CD154 Blockade for Induction of Mixed Chimerism and Prolonged Renal Allograft Survival in Nonhuman Primates Tatsuo Kawai, Hiroshi Sogawa, Svetlan Boskovic, American Journal of Transplantation	2004	197
Progress towards a public chemogenomic set for protein kinases and a call for contributions David H. Drewry, Carrow I. Wells, David Andrews, PLoS ONE Drug TargetPublic Chemogenomic SetMolecular BiologyTumor BiologyReceptor Tyrosine Kinase	2017	166
Optimization of a Novel Binding Motif to (<i>E</i>)-3-(3,5-Difluoro-4-((1<i>R</i>,3<i>R</i>)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indol-1-yl)phenyl)acrylic Acid (AZD9496), a Potent and Orally Bioavailable Selective Estrogen Receptor Downregulator and Antagonist Chris De Savi, Robert H. Bradbury, Alfred A. Rabow, Journal of Medicinal Chemistry Pharmaceutical SciencePharmacotherapyPositive Breast CancerPharmaceutical ChemistryMolecular Pharmacology	2015	159
Depletion of anti‐Galα1–3Gal antibody in baboons by specific α‐Gal immunoaffinity columns Tomasz Kozłowski, Francesco L. Ierino, Denis Lambrigts, Xenotransplantation	1998	118
Are humans able to voluntarily elicit maximum muscle force? James J. Dowling, Ellen Konert, Paul Ljucovic, Neuroscience Letters Muscle FunctionKinesiologyMaximum Muscle ForceMuscle InjuryExercise	1994	114
Isolation and Partial Characterization of a Glial Hyaluronate-binding Protein George Perides, W S Lane, David Andrews, Journal of Biological Chemistry	1989	113
Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys1 Tatsuo Kawai, A. Benedict Cosimi, S L Wee, Transplantation	2002	111
The Kinase Chemogenomic Set (KCGS): An Open Science Resource for Kinase Vulnerability Identification Carrow I. Wells, Hassan Al‐Ali, David Andrews, International Journal of Molecular Sciences Drug TargetSelective Kinase InhibitorsMolecular BiologyBioinformatics DatabaseTumor Biology	2021	105
Solid‐phase synthesis of a range of O‐phosphorylated peptides by post‐assembly phosphitylation and oxidation David Andrews, John R. Kitchin, Peter W. Seale International journal of peptide & protein research	1991	91
Optimization of Novel Acyl Pyrrolidine Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase Leading to a Development Candidate Martin J. Slater, Elizabeth M. Amphlett, David Andrews, Journal of Medicinal Chemistry Hcv RepliconDevelopment CandidateMolecular BiologyPyrrolidine-based TemplateAntiviral Drug	2007	90

Page 1